227 related articles for article (PubMed ID: 33963835)
1. Driveline exit-site care protocols in patients with left ventricular assist devices: a systematic review.
Koken ZO; Yalcin YC; van Netten D; de Bakker CC; van der Graaf M; Kervan U; Verkaik NJ; Caliskan K
Eur J Cardiothorac Surg; 2021 Sep; 60(3):506-515. PubMed ID: 33963835
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular assist device driveline infection and the frequency of dressing change in hospitalized patients.
Wus L; Manning M; Entwistle JW
Heart Lung; 2015; 44(3):225-9. PubMed ID: 25746483
[TBL] [Abstract][Full Text] [Related]
3. Wound care of the driveline exit site in patients with a ventricular assist device: A systematic review.
Özdemir Z; Şenol Çelik S
Turk Gogus Kalp Damar Cerrahisi Derg; 2018 Apr; 26(2):328-335. PubMed ID: 32082759
[TBL] [Abstract][Full Text] [Related]
4. A simple device to secure ventricular assist device driveline and prevent exit-site infection.
Baronetto A; Centofanti P; Attisani M; Ricci D; Mussa B; Devotini R; Simonato E; Rinaldi M
Interact Cardiovasc Thorac Surg; 2014 Apr; 18(4):415-7. PubMed ID: 24431003
[TBL] [Abstract][Full Text] [Related]
5. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.
Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH
Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699
[TBL] [Abstract][Full Text] [Related]
6. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections.
Cagliostro B; Levin AP; Fried J; Stewart S; Parkis G; Mody KP; Garan AR; Topkara V; Takayama H; Naka Y; Jorde UP; Uriel N
J Heart Lung Transplant; 2016 Jan; 35(1):108-114. PubMed ID: 26476767
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort study.
Pitton M; Valente LG; Oberhaensli S; Casanova C; Sendi P; Schnegg B; Jakob SM; Cameron DR; Que YA; Fürholz M
J Heart Lung Transplant; 2023 Oct; 42(10):1445-1454. PubMed ID: 37245557
[TBL] [Abstract][Full Text] [Related]
8. Risk of left ventricular assist device driveline infection: A systematic literature review.
Pavlovic NV; Randell T; Madeira T; Hsu S; Zinoviev R; Abshire M
Heart Lung; 2019; 48(2):90-104. PubMed ID: 30573195
[TBL] [Abstract][Full Text] [Related]
9. Driveline dressings used in heartmate patients and local complications: A retrospective cohort.
Balestra N; Fredericks S; Silva AVCD; Rodrigues RCM; Nunes DP; Pedrosa RBDS
Heart Lung; 2023; 62():271-277. PubMed ID: 37633011
[TBL] [Abstract][Full Text] [Related]
10. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.
Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L
Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225
[TBL] [Abstract][Full Text] [Related]
11. Double tunnel technique for the LVAD driveline: improved management regarding driveline infections.
Schibilsky D; Benk C; Haller C; Berchtold-Herz M; Siepe M; Beyersdorf F; Schlensak C
J Artif Organs; 2012 Mar; 15(1):44-8. PubMed ID: 21987183
[TBL] [Abstract][Full Text] [Related]
12. Substantial Reduction in Driveline Infection Rates With the Modification of Driveline Dressing Protocol.
Lander MM; Kunz N; Dunn E; Althouse AD; Lockard K; Shullo MA; Kormos RL; Teuteberg JJ
J Card Fail; 2018 Nov; 24(11):746-752. PubMed ID: 30098380
[TBL] [Abstract][Full Text] [Related]
13. Left ventricle assist devices and driveline's infection incidence: a single-centre experience.
Bejko J; Toto F; Gregori D; Gerosa G; Bottio T
J Artif Organs; 2018 Mar; 21(1):52-60. PubMed ID: 28988400
[TBL] [Abstract][Full Text] [Related]
14. Reduction of INCOR® driveline infection rate with silicone at the driveline exit site.
Camboni D; Zerdzitzki M; Hirt S; Tandler R; Weyand M; Schmid C
Interact Cardiovasc Thorac Surg; 2017 Feb; 24(2):222-228. PubMed ID: 27702831
[TBL] [Abstract][Full Text] [Related]
15. Reduce Driveline Trauma Through Stabilization and Exit Site Management: 30 Days Feasibility Results from the Multicenter RESIST Study.
Stahovich M; Sundareswaran KS; Fox S; Hallinan W; Blood P; Chen L; Pamboukian SV; Chinn R; Farrar DJ; Pagani FD; Blue L
ASAIO J; 2016; 62(3):240-5. PubMed ID: 27111738
[TBL] [Abstract][Full Text] [Related]
16. Prevention and early treatment of driveline infections in ventricular assist device patients - The DESTINE staging proposal and the first standard of care protocol.
Bernhardt AM; Schlöglhofer T; Lauenroth V; Mueller F; Mueller M; Schoede A; Klopsch C;
J Crit Care; 2020 Apr; 56():106-112. PubMed ID: 31896443
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Success With Driveline Exit Site Relocation for Deep Driveline Infection in Left Ventricular Assist Device Patients.
Balsam LB; Jacoby A; Louie E; Levine JP
Innovations (Phila); 2017; 12(6):440-445. PubMed ID: 29232297
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic negative pressure wound therapy is not effective for preventing driveline infection following left ventricular assist device implantation.
Tsuji M; Kakuda N; Bujo C; Saito A; Ishida J; Amiya E; Hatano M; Shimada A; Imai H; Kimura M; Ando M; Kinoshita O; Yamauchi H; Komuro I; Ono M
Artif Organs; 2023 Mar; 47(3):566-573. PubMed ID: 36300650
[TBL] [Abstract][Full Text] [Related]
19. Ventricular Assist Device Driveline Infections: A Systematic Review.
Krzelj K; Petricevic M; Gasparovic H; Biocina B; McGiffin D
Thorac Cardiovasc Surg; 2022 Sep; 70(6):493-504. PubMed ID: 34521143
[TBL] [Abstract][Full Text] [Related]
20. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
